Adenosine deaminase acting on RNA 1 accelerates cell cycle through increased translation and activity of cyclin-dependent kinase 2

Shock

Volumn 27, Issue 2, 2007, Pages 214-219

  Zhang, Fangming ^a   Rabinovici, Reuven ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADAR1; Cell cycle; Inflammation; RNA editing

Indexed keywords

ADENOSINE DEAMINASE ACTING ON RNA 1 PROTEIN; ANTIBODY; CYCLIN A; CYCLIN DEPENDENT KINASE 2; HISTONE H1; ISOPROTEIN; KENPAULLONE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME REGULATION; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTER; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOPRECIPITATION; INFLAMMATION; NITROBLUE TETRAZOLIUM TEST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA EDITING; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

ADENOSINE DEAMINASE; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE 2; HUMANS; PROTEIN BIOSYNTHESIS; TRANSFECTION; UP-REGULATION;

EID: 33846202449     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000238072.51653.f2     Document Type: Article

References (29)

1. Hough RF, Bass BL: Adenosine deaminases that act on RNA. In Bass BL (ed.): RNA Editing: Frontiers in Molecular Biology. Oxford, United Kingdom: Oxford University Press, 2001.
2. Bass BL: RNA editing and hypermutation by adenosine deamination. Trends Biochem Sci 22:157-162, 1997.
3. Sommer B, Kohler M, Sprengel R, Seeburg PH: RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11-19, 1991.
4. Morse DP, Aruscavage PJ, Bass BL: RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc Natl Acad Sci U S A 99:7906-7911, 2002.
5. Maas S, Rich A, Nishikura K: A-to-I RNA editing. Recent news and residual mysteries. J Biol Chem 278:1391-1394, 2003.
6. Valente L, Nishikura K: ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 79:299-338, 2005.
7. Wang Q, Khillan J, Gadue P, Nishikura K: Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765-1768, 2000.
8. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K: Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279:4952-4961, 2004.
9. Lei M, Liu Y, Samuel CE: Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. Virology 245:188-196, 1998.
10. Rabinovici R, Kabir K, Chen M, Su Y, Zhang D, Luo X, Yang JH: ADAR1 is involved in the development of microvascular lung injury. Circ Res 88: 1066-1071, 2001.
11. Yang JH, Luo X, Nie YZ, Su YJ, Zhao QC, Kabir K, Zhang DX, Rabinovici R: Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 109:15-23, 2003.
12. Yang JH, Nie YZ, Zhao OC, Su YJ, Pypaert M, Su H, Rabinovici R: Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J Biol Chem 278:45833-45842, 2003.
13. Groschel B, Bushman F: Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus. J Virol 79:5695-5704, 2005.
14. Sugai M, Kawamoto T, Peres SY, Ueno Y, Komatsuzawa H, Fujiware T, Suginaka H, Oswald E: The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 66:5008-5019, 1998.
15. 2 arrest in the phytopathogenic fungus. Eukaryot Cell 2:494-500, 2003.
16. Satomoto K, Haisa M, Naomoto Y, Tanaka N, Orita K: Cyclin A and Cdk2 kinase activity are suppressed by combined treatment with tumor necrosis factor-alpha and interferon-alpha. Biochem Biophys Res Commun 213:1115-1121, 1995.
17. Shen WH, Yin Y, Broussark SR, McCusker RH, Freund GG, Dantzer R, Kelley KW: Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem 279:7438-7446, 2004.
18. Murphy D, Detjen KM, Welzel M, Wiedenmann B, Rosewicz S: Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases. Hepatology 33:346-356, 2001.
19. Pines J: Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci 18:195-197, 1993.
20. Van den Heuvel S, Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054, 1993.
21. Nigg EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480, 1995.
22. Pines J: Four-dimensional control of the cell cycle. Nat Cell Biol 1:E73-E79, 1999.
23. Pan ZQ, Hurwitz J: Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro. J Biol Chem 268:20433-20442, 1993.
24. Yang R, Morosetti R, Koeffler HP: Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res 57:913-920, 1997.
25. Ekholm SV, Reed SI: Regulation of G (1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12:676-684, 2000.
26. Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59:1317-1326, 2002.
27. Nie Y, Zhao Q, Su Y, Yang JH: Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif. J Biol Chem 279:13249-13255, 2004.
28. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA: Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26:182-190, 2002.
29. Buolamwini JK: Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6:379-392, 2000.